BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Y, Lower EE, Li H, Baughman RP. Clinical management of pulmonary sarcoidosis. Expert Review of Respiratory Medicine 2016;10:577-91. [DOI: 10.1586/17476348.2016.1164602] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Régis C, Benali K, Rouzet F. FDG PET/CT imaging of sarcoidosis. Seminars in Nuclear Medicine 2022. [DOI: 10.1053/j.semnuclmed.2022.08.004] [Reference Citation Analysis]
2 Jaleel J, Sagar S, Kumar R. Utility of PET/Computed Tomography in Infection and Inflammation Imaging. PET Clin 2022;17:533-42. [PMID: 35717106 DOI: 10.1016/j.cpet.2022.02.004] [Reference Citation Analysis]
3 Zhang Y, Du S, Zhao M, Li Q, Zhou Y, Song J, Chen T, Shi J, Jie B, Li W, Shen L, Zhang F, Su Y, Hu Y, Lower EE, Baughman RP, Li H. Chest high-resolution computed tomography can make higher accurate stages for thoracic sarcoidosis than X-ray. BMC Pulm Med 2022;22. [DOI: 10.1186/s12890-022-01942-y] [Reference Citation Analysis]
4 Shen M, Zhou Y, Gu W, Yin C, Wang Y, Zhang Y. Application of neck ultrasound in the diagnosis of sarcoidosis. BMC Pulm Med 2021;21:412. [PMID: 34911526 DOI: 10.1186/s12890-021-01769-z] [Reference Citation Analysis]
5 Bloem AEM, Mostard RLM, Stoot N, Vercoulen JH, Peters JB, Spruit MA. Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis. J Thorac Dis 2021;13:4872-84. [PMID: 34527326 DOI: 10.21037/jtd-21-462] [Reference Citation Analysis]
6 Bloem AEM, Mostard RLM, Stoot N, Vercoulen JH, Peters JB, Janssen DJA, Custers JWH, Spruit MA. Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis. J Clin Med 2020;9:E1178. [PMID: 32325989 DOI: 10.3390/jcm9041178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
7 Aryal S, Nathan SD. Contemporary optimized practice in the management of pulmonary sarcoidosis. Ther Adv Respir Dis 2019;13:1753466619868935. [PMID: 31409257 DOI: 10.1177/1753466619868935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
8 Miyata J, Ogawa T, Tagami Y, Sato T, Nagayama M, Hirano T, Kameyama N, Fukunaga K, Kawana A, Inoue T. Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2020;37:8-16. [PMID: 33093764 DOI: 10.36141/svdld.v37i1.8313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Al-Omar HA, Sherif HM, Mayet AY. Vaccination status of patients using anti-TNF therapy and the physicians' behavior shaping the phenomenon: Mixed-methods approach. PLoS One 2019;14:e0223594. [PMID: 31584996 DOI: 10.1371/journal.pone.0223594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
10 Llabres M, Brito-Zerón P, Ramos-Casals M, Sellares J. Synthetic pharmacotherapy for pulmonary sarcoidosis. Expert Opin Pharmacother 2019;20:1397-404. [PMID: 31090462 DOI: 10.1080/14656566.2019.1615054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
11 West SG. Current management of sarcoidosis I: pulmonary, cardiac, and neurologic manifestations. Curr Opin Rheumatol 2018;30:243-8. [PMID: 29389828 DOI: 10.1097/BOR.0000000000000489] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
12 Denson K, Herbein M, Stewart F. Pulmonary Sarcoidosis Considerations in Primary Care. The Journal for Nurse Practitioners 2018;14:710-7. [DOI: 10.1016/j.nurpra.2018.09.006] [Reference Citation Analysis]
13 Piekarski E, Benali K, Rouzet F. Nuclear Imaging in Sarcoidosis. Seminars in Nuclear Medicine 2018;48:246-60. [DOI: 10.1053/j.semnuclmed.2018.02.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]